294 related articles for article (PubMed ID: 29138570)
1. Erratum: Quick reference guide to apixaban [Corrigendum].
Vasc Health Risk Manag; 2017; 13():413. PubMed ID: 29138570
[TBL] [Abstract][Full Text] [Related]
2. Corrigendum.
Paediatr Child Health; 2015; 20(8):466-7. PubMed ID: 26744561
[TBL] [Abstract][Full Text] [Related]
3. Corrigendum.
J Indian Soc Periodontol; 2021; 25(3):270. PubMed ID: 34158698
[TBL] [Abstract][Full Text] [Related]
4. Erratum: A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban [Corrigendum.
Clin Pharmacol; 2018; 10():71. PubMed ID: 29928148
[TBL] [Abstract][Full Text] [Related]
5. Corrigendum.
Sun XH; Yu HZ; Yang MM; Yang YM; Dang ZM
J Cachexia Sarcopenia Muscle; 2015 Jun; 6(2):192. PubMed ID: 26140254
[TBL] [Abstract][Full Text] [Related]
6. Erratum: Polyethylenimine-based micro/nanoparticles as vaccine adjuvants [Corrigendum].
Int J Nanomedicine; 2017; 12():7239. PubMed ID: 29042772
[TBL] [Abstract][Full Text] [Related]
7. Erratum: Drug prescription appropriateness in the elderly: an Italian study [Corrigendum].
Clin Interv Aging; 2017; 12():2131. PubMed ID: 29290683
[TBL] [Abstract][Full Text] [Related]
8. Erratum: Ex vivo distribution of gold nanoparticles in choroidal melanoma [Corrigendum].
Int J Nanomedicine; 2018; 13():1295. PubMed ID: 29569644
[TBL] [Abstract][Full Text] [Related]
9. Erratum: Antibacterial properties and toxicity from metallic nanomaterials [Corrigendum].
Int J Nanomedicine; 2018; 13():6497. PubMed ID: 30410334
[TBL] [Abstract][Full Text] [Related]
10. Erratum: Predicting frequent COPD exacerbations using primary care data [Corrigendum].
Int J Chron Obstruct Pulmon Dis; 2018; 13():2471. PubMed ID: 30147313
[TBL] [Abstract][Full Text] [Related]
11. Erratum: Antioxidant and hepatoprotective role of selenium against silver nanoparticles [Corrigendum].
Int J Nanomedicine; 2018; 13():5769. PubMed ID: 30310279
[TBL] [Abstract][Full Text] [Related]
12. Erratum: Frequency of frailty and its association with cognitive status and survival in older Chileans [Corrigendum].
Clin Interv Aging; 2018; 13():1043. PubMed ID: 29872282
[TBL] [Abstract][Full Text] [Related]
13. Erratum: Development of transmucosal patch loaded with anesthetic and analgesic for dental procedures and in vivo evaluation [Corrigendum].
Int J Nanomedicine; 2018; 13():1867. PubMed ID: 29628762
[TBL] [Abstract][Full Text] [Related]
14. Erratum: The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia [Corrigendum].
Int J Chron Obstruct Pulmon Dis; 2016; 11():417. PubMed ID: 27013872
[TBL] [Abstract][Full Text] [Related]
15. Erratum: Bronchiectasis in COPD patients: more than a comorbidity? [Corrigendum].
Int J Chron Obstruct Pulmon Dis; 2019; 14():245. PubMed ID: 30718950
[TBL] [Abstract][Full Text] [Related]
16. Erratum: corrigendum.
Clin Ophthalmol; 2011; 5():1557. PubMed ID: 22125401
[TBL] [Abstract][Full Text] [Related]
17. Erratum: Treatment of a multiple sclerosis animal model by a novel nanodrop formulation of a natural antioxidant [Corrigendum].
Int J Nanomedicine; 2018; 13():4845. PubMed ID: 30214192
[TBL] [Abstract][Full Text] [Related]
18. Erratum: Cooperation of IRAK1/4 inhibitor and ABT-737 in nanoparticles for synergistic therapy of T cell acute lymphoblastic leukemia [Corrigendum].
Int J Nanomedicine; 2018; 13():615. PubMed ID: 29443320
[TBL] [Abstract][Full Text] [Related]
19. Erratum: Bypassing the EPR effect with a nanomedicine harboring a sustained-release function allows better tumor control [Corrigendum].
Int J Nanomedicine; 2017; 12():8101. PubMed ID: 29138565
[TBL] [Abstract][Full Text] [Related]
20. Erratum: Development of an integral assessment approach of health status in patients with obstructive airway diseases: the CORONA study [Corrigendum].
Int J Chron Obstruct Pulmon Dis; 2016; 11():191. PubMed ID: 26889083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
